CORD-19:ee0a7632371a08727d41e55aad7d621daeceef7d / 202897-203126 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"T89035","span":{"begin":0,"end":229},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In this study, we explore the utility of next-generation sequencing (NGS) for the clinical characterization of IGHV in a cohort of SMZL and compare it to other subtypes of marginal zone lymphomas (MZL) reported in the literature."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T198","span":{"begin":0,"end":229},"obj":"Sentence"}],"text":"In this study, we explore the utility of next-generation sequencing (NGS) for the clinical characterization of IGHV in a cohort of SMZL and compare it to other subtypes of marginal zone lymphomas (MZL) reported in the literature."}

    CORD-19-PD-HP

    {"project":"CORD-19-PD-HP","denotations":[{"id":"T560","span":{"begin":186,"end":195},"obj":"Phenotype"}],"attributes":[{"id":"A560","pred":"hp_id","subj":"T560","obj":"http://purl.obolibrary.org/obo/HP_0002665"}],"text":"In this study, we explore the utility of next-generation sequencing (NGS) for the clinical characterization of IGHV in a cohort of SMZL and compare it to other subtypes of marginal zone lymphomas (MZL) reported in the literature."}

    CORD-19-PD-MONDO

    {"project":"CORD-19-PD-MONDO","denotations":[{"id":"T1392","span":{"begin":131,"end":135},"obj":"Disease"},{"id":"T1393","span":{"begin":172,"end":195},"obj":"Disease"},{"id":"T1394","span":{"begin":197,"end":200},"obj":"Disease"},{"id":"T32991","span":{"begin":131,"end":135},"obj":"Disease"},{"id":"T26451","span":{"begin":172,"end":195},"obj":"Disease"},{"id":"T38611","span":{"begin":197,"end":200},"obj":"Disease"}],"attributes":[{"id":"A1392","pred":"mondo_id","subj":"T1392","obj":"http://purl.obolibrary.org/obo/MONDO_0019462"},{"id":"A1393","pred":"mondo_id","subj":"T1393","obj":"http://purl.obolibrary.org/obo/MONDO_0017604"},{"id":"A1394","pred":"mondo_id","subj":"T1394","obj":"http://purl.obolibrary.org/obo/MONDO_0017604"},{"id":"A4082","pred":"mondo_id","subj":"T32991","obj":"http://purl.obolibrary.org/obo/MONDO_0019462"},{"id":"A39898","pred":"mondo_id","subj":"T26451","obj":"http://purl.obolibrary.org/obo/MONDO_0017604"},{"id":"A39232","pred":"mondo_id","subj":"T38611","obj":"http://purl.obolibrary.org/obo/MONDO_0017604"}],"text":"In this study, we explore the utility of next-generation sequencing (NGS) for the clinical characterization of IGHV in a cohort of SMZL and compare it to other subtypes of marginal zone lymphomas (MZL) reported in the literature."}